Does the immune reaction cause malignant transformation by disrupting cell-to-cell or cell-to-matrix communications?
- PMID: 17480231
- PMCID: PMC1871575
- DOI: 10.1186/1742-4682-4-16
Does the immune reaction cause malignant transformation by disrupting cell-to-cell or cell-to-matrix communications?
Abstract
TUMOR PROGRESSION: In many (perhaps in all) tumor systems, a malignant cancer is preceded by a benign lesion. Most benign lesions do not transform to malignancy and many regress. The final transformative step to malignancy differs from the preceding steps in, among other things, that it often occurs in the absence of the original carcinogenic stimulus.
Mechanism of immunostimulation: Relatively low titers of specific immune reactants are known to stimulate, but cell-to-cell or cell-to-matrix interactions appear to be major inhibitors of tumor-growth. Therefore, it seems reasonable to hypothesize that the mechanism of immunostimulation may be an interference with cell-to-cell or cell-to-matrix communication by a sub-lethal immune-reaction.
Discussion: While the above hypothesis remains unproven, some evidence suggests that immunity may have a major facilitating effect on tumor growth especially at the time of malignant transformation. There is even some evidence suggesting that transformation in vivo may seldom occur in the absence of immunostimulation of the premalignant lesion. Positive selection by the immune reaction may be the reason that tumors are immunogenic.
Figures
Similar articles
-
Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis.Cancer Metastasis Rev. 2010 Jun;29(2):295-307. doi: 10.1007/s10555-010-9221-8. Cancer Metastasis Rev. 2010. PMID: 20386958 Review.
-
The fundamental role of mechanical properties in the progression of cancer disease and inflammation.Rep Prog Phys. 2014 Jul;77(7):076602. doi: 10.1088/0034-4885/77/7/076602. Epub 2014 Jul 9. Rep Prog Phys. 2014. PMID: 25006689 Review.
-
New insights into the role of extracellular matrix during tumor onset and progression.J Cell Physiol. 2002 Sep;192(3):259-67. doi: 10.1002/jcp.10142. J Cell Physiol. 2002. PMID: 12124771 Review.
-
Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells.Differentiation. 2002 Dec;70(9-10):486-97. doi: 10.1046/j.1432-0436.2002.700903.x. Differentiation. 2002. PMID: 12492491 Review.
-
Proinvasive extracellular matrix remodeling for tumor progression.Arch Pharm Res. 2019 Jan;42(1):40-47. doi: 10.1007/s12272-018-1097-0. Epub 2018 Dec 4. Arch Pharm Res. 2019. PMID: 30515725 Review.
Cited by
-
Emerging concepts in CD8(+) T regulatory cells.Curr Opin Immunol. 2008 Jun;20(3):327-31. doi: 10.1016/j.coi.2008.02.003. Epub 2008 Apr 10. Curr Opin Immunol. 2008. PMID: 18406591 Free PMC article. Review.
-
Immunoediting: evidence of the multifaceted role of the immune system in self-metastatic tumor growth.Theor Biol Med Model. 2012 Jul 28;9:31. doi: 10.1186/1742-4682-9-31. Theor Biol Med Model. 2012. PMID: 22838395 Free PMC article.
-
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness.J Exp Med. 2008 Jul 7;205(7):1687-700. doi: 10.1084/jem.20072016. Epub 2008 Jun 23. J Exp Med. 2008. PMID: 18573907 Free PMC article.
-
A new kink in an old theory of carcinogenesis.Theor Biol Med Model. 2013 Feb 18;10:12. doi: 10.1186/1742-4682-10-12. Theor Biol Med Model. 2013. PMID: 23414486 Free PMC article.
-
Tumor inhibitory T cell immunity may be largely a transplantation artifact not necessarily dependent upon a lack of Tregs.Theor Biol Med Model. 2013 Jun 25;10:42. doi: 10.1186/1742-4682-10-42. Theor Biol Med Model. 2013. PMID: 23800315 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials